Oncolytic herpes simplex virus-1 G207 induces cyclooxygenase-2 gene expression by activation of the mitogen activated protein kinase pathway

被引：0
作者：
Kim, TH
Bhargava, A
Stiles, BM
Wong, RJ
Fong, YM
Dannenberg, AJ
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] New York Presbyterian Hosp Cornell, Dept Med, New York, NY USA
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1175
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [1] Oncolytic viral therapy for human prostate cancer by conditionally replicating herpes simplex virus 1 vector G207
    Oyama, M
    Ohigashi, T
    Hoshi, M
    Murai, M
    Uyemura, K
    Yazaki, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (12): : 1339 - 1344
  • [2] Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy
    Coukos, G
    Makrigiannakis, A
    Montas, S
    Kaiser, LR
    Toyozumi, T
    Benjamin, I
    Albelda, SM
    Rubin, SC
    Molnar-Kimber, KL
    CANCER GENE THERAPY, 2000, 7 (02) : 275 - 283
  • [3] Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy
    George Coukos
    Antonis Makrigiannakis
    Sacha Montas
    Larry R Kaiser
    Takane Toyozumi
    Ivor Benjamin
    Steven M Albelda
    Stephen C Rubin
    Katherine L Molnar-Kimber
    Cancer Gene Therapy, 2000, 7 : 275 - 283
  • [4] AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-β-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway
    Chang, Mei-Ying
    Ho, Feng-Ming
    Wang, Jang-Shiun
    Kang, Hao-Cheng
    Chang, Yung
    Ye, Zhi-Xian
    Lin, Wan-Wan
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (08) : 1210 - 1220
  • [5] Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus-1 G207 in Pediatric Malignant Supratentorial Brain Tumors
    Bernstock, Joshua D.
    Wright, Zachary
    Bag, Asim K.
    Gessler, Florian
    Gillespie, George Yancey
    Markert, James M.
    Friedman, Gregory K.
    Johnston, James M.
    WORLD NEUROSURGERY, 2019, 122 : E1592 - E1598
  • [6] Treatment of recurrent malignant glioma with G207, a genetically engineered herpes simplex virus-1, followed by irradiation: Phase I study results
    Karrasch, M.
    Gillespie, G. Y.
    Braz, E.
    Liechty, P. G.
    Nabors, L. B.
    Lakeman, A. D.
    Palmer, C. A.
    Parker, J. N.
    Whitley, R. J.
    Markert, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors
    Todo, T
    Rabkin, SD
    Martuza, RL
    CANCER GENE THERAPY, 2000, 7 (06) : 939 - 946
  • [8] Activation of the mitogen-activated protein kinase pathway induces transcription of the PAC-1 phosphatase gene
    Grumont, RJ
    Rasko, JEJ
    Strasser, A
    Gerondakis, S
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (06) : 2913 - 2921
  • [9] Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors
    Tomoki Todo
    Samuel D Rabkin
    Robert L Martuza
    Cancer Gene Therapy, 2000, 7 : 939 - 946
  • [10] Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207)
    Kooby, DA
    Carew, JF
    Halterman, MW
    Mack, JE
    Bertino, JR
    Blumgart, LH
    Federoff, HJ
    Fong, YM
    FASEB JOURNAL, 1999, 13 (11) : 1325 - 1334
12345